Global Health Limited (ASX:GLH)
Australia
· Delayed Price · Currency is AUD 0.0690
-0.0020 (-2.82%)
At close: Mar 6, 2026
Global Health Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2020 - 2016 |
| Operating Revenue | 7.28 | 7.32 | 8.12 | 7.82 | 6.54 | 7.03 | Upgrade
|
| Other Revenue | 1.19 | 1.35 | 0.54 | - | - | - | Upgrade
|
| Revenue | 8.46 | 8.67 | 8.66 | 7.82 | 6.54 | 7.03 | Upgrade
|
| Revenue Growth (YoY) | -5.50% | 0.08% | 10.75% | 19.61% | -7.01% | 12.48% | Upgrade
|
| Cost of Revenue | 6.48 | 6.57 | 6.12 | 7.31 | 6.6 | 5.6 | Upgrade
|
| Gross Profit | 1.98 | 2.1 | 2.54 | 0.51 | -0.06 | 1.43 | Upgrade
|
| Selling, General & Admin | 0.76 | 0.74 | 1.02 | 1.51 | 1.32 | 0.93 | Upgrade
|
| Research & Development | 1.86 | 2.1 | 2.69 | 2.21 | 0.31 | - | Upgrade
|
| Amortization of Goodwill & Intangibles | - | - | - | 0.48 | 0.28 | 0.41 | Upgrade
|
| Operating Expenses | 2.69 | 2.9 | 3.76 | 4.24 | 1.91 | 1.45 | Upgrade
|
| Operating Income | -0.71 | -0.8 | -1.23 | -3.73 | -1.98 | -0.01 | Upgrade
|
| Interest Expense | -0.14 | -0.11 | -0.03 | -0 | -0 | -0.01 | Upgrade
|
| Interest & Investment Income | 0.02 | 0.03 | 0.01 | 0 | 0 | 0 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.01 | -0.01 | -0.02 | -0.06 | -0.01 | -0 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.02 | 0.02 | -0.05 | -0.01 | -0.03 | 0.39 | Upgrade
|
| EBT Excluding Unusual Items | -0.81 | -0.87 | -1.31 | -3.8 | -2.01 | 0.37 | Upgrade
|
| Asset Writedown | - | - | - | -3.9 | - | -1 | Upgrade
|
| Pretax Income | -0.81 | -0.87 | -1.31 | -7.7 | -2.01 | -0.63 | Upgrade
|
| Income Tax Expense | - | - | - | 0.35 | 0.04 | -0.14 | Upgrade
|
| Earnings From Continuing Operations | -0.81 | -0.87 | -1.31 | -8.05 | -2.05 | -0.49 | Upgrade
|
| Net Income | -0.81 | -0.87 | -1.31 | -8.05 | -2.05 | -0.49 | Upgrade
|
| Net Income to Common | -0.81 | -0.87 | -1.31 | -8.05 | -2.05 | -0.49 | Upgrade
|
| Shares Outstanding (Basic) | 59 | 58 | 58 | 58 | 56 | 42 | Upgrade
|
| Shares Outstanding (Diluted) | 59 | 58 | 58 | 58 | 56 | 42 | Upgrade
|
| Shares Change (YoY) | 0.78% | 0.27% | 0.92% | 2.71% | 32.20% | 8.50% | Upgrade
|
| EPS (Basic) | -0.01 | -0.01 | -0.02 | -0.14 | -0.04 | -0.01 | Upgrade
|
| EPS (Diluted) | -0.01 | -0.01 | -0.02 | -0.14 | -0.04 | -0.01 | Upgrade
|
| Free Cash Flow | -0.32 | -0.71 | -1.15 | -3.47 | -1.19 | 1.37 | Upgrade
|
| Free Cash Flow Per Share | -0.01 | -0.01 | -0.02 | -0.06 | -0.02 | 0.03 | Upgrade
|
| Gross Margin | 23.39% | 24.21% | 29.31% | 6.54% | -0.99% | 20.39% | Upgrade
|
| Operating Margin | -8.37% | -9.25% | -14.15% | -47.70% | -30.23% | -0.16% | Upgrade
|
| Profit Margin | -9.56% | -10.00% | -15.15% | -103.03% | -31.35% | -6.94% | Upgrade
|
| Free Cash Flow Margin | -3.79% | -8.15% | -13.29% | -44.40% | -18.21% | 19.50% | Upgrade
|
| EBITDA | -0.7 | -0.79 | -1.22 | -3.72 | -1.97 | 0 | Upgrade
|
| EBITDA Margin | -8.25% | -9.15% | -14.09% | -47.63% | -30.18% | 0.01% | Upgrade
|
| D&A For EBITDA | 0.01 | 0.01 | 0.01 | 0.01 | 0 | 0.01 | Upgrade
|
| EBIT | -0.71 | -0.8 | -1.23 | -3.73 | -1.98 | -0.01 | Upgrade
|
| EBIT Margin | -8.37% | -9.25% | -14.15% | -47.70% | -30.23% | -0.16% | Upgrade
|
| Revenue as Reported | 8.48 | 8.7 | 8.67 | 7.82 | 6.54 | 7.48 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.